Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Escape after Hematopoietic Stem Cell Transplantation (HSCT): From Mechanisms to Novel Therapies
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 69
Publisher
MDPI AG
Online
2019-12-26
DOI
10.3390/cancers12010069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monitoring TIGIT/DNAM-1 and PVR/PVRL2 immune checkpoint's expression levels in allogeneic stem cell transplantation for acute myeloid leukemia
- (2019) Norimichi Hattori et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
- (2019) Maddalena Noviello et al. Nature Communications
- Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
- (2019) Cristina Toffalori et al. NATURE MEDICINE
- CD123 CAR T Cells for the Treatment of Myelodysplastic Syndrome
- (2019) Brett M. Stevens et al. EXPERIMENTAL HEMATOLOGY
- Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies
- (2019) Florence Borot et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
- (2019) Beatriz Sanchez-Correa et al. Cancers
- Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies
- (2019) Greta de Jong et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study
- (2019) Farhad Ravandi et al. Lancet Haematology
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Epidemiology and biology of relapse after stem cell transplantation
- (2018) Mary Horowitz et al. BONE MARROW TRANSPLANTATION
- Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia
- (2018) Miriam Y. Kim et al. CELL
- PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model
- (2018) Rui Deng et al. Hematology
- Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
- (2018) Ying Wang et al. Journal of Hematology & Oncology
- CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
- (2018) Jinghua Wang et al. Journal of Hematology & Oncology
- CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
- (2018) Hardikkumar Jetani et al. LEUKEMIA
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
- (2018) Nimitha R Mathew et al. NATURE MEDICINE
- Donor lymphocyte infusion in myeloid disorders
- (2018) Selami Koçak Toprak TRANSFUSION AND APHERESIS SCIENCE
- A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
- (2018) Arjan A. van de Loosdrecht et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
- (2018) Richard F. Schlenk et al. BLOOD
- Mechanisms of immune escape after allogeneic hematopoietic cell transplantation
- (2018) Robert Zeiser et al. BLOOD
- The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
- (2018) Patrick Williams et al. CANCER
- Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2
- (2018) Olivier Humbert et al. LEUKEMIA
- Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
- (2018) Matthew J. Christopher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study
- (2018) Naval Daver et al. Cancer Discovery
- Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia
- (2017) Alison A. Laing et al. EXPERIMENTAL HEMATOLOGY
- Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation
- (2017) Thomas Schroeder et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia
- (2017) E Bernson et al. LEUKEMIA
- Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner
- (2017) P Peña-Martínez et al. LEUKEMIA
- Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
- (2017) Haruko Tashiro et al. MOLECULAR THERAPY
- Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
- (2017) R. Coleman Lindsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
- (2017) Anne-Sophie Chretien et al. Oncotarget
- Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
- (2017) Aroa Baragaño Raneros et al. Oncotarget
- NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
- (2017) Anne-Sophie Chretien et al. OncoImmunology
- Hematopoietic stem cell transplantation and cellular therapy
- (2017) H.-J. Kolb HLA
- CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression
- (2016) Anuradha Tarafdar et al. BLOOD
- Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the
- (2016) Sebastian Giebel et al. CANCER
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
- (2016) Michael D. Buck et al. CELL
- T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
- (2016) Y. Kong et al. CLINICAL CANCER RESEARCH
- Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
- (2016) Anas Younes et al. LANCET ONCOLOGY
- Ipilimumab for Patients with Relapse after Allogeneic Transplantation
- (2016) Matthew S. Davids et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
- (2016) J. Rosenblatt et al. Science Translational Medicine
- Epigenetics in Cancer: A Hematological Perspective
- (2016) Maximilian Stahl et al. PLoS Genetics
- Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
- (2015) A Hamdi et al. BONE MARROW TRANSPLANTATION
- Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
- (2015) Z Jedlickova et al. BONE MARROW TRANSPLANTATION
- Cancer Neoantigens and Applications for Immunotherapy
- (2015) A. Desrichard et al. CLINICAL CANCER RESEARCH
- T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment
- (2015) Frauke M. Schnorfeil et al. Journal of Hematology & Oncology
- Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion
- (2015) Zena Khaznadar et al. JOURNAL OF IMMUNOLOGY
- CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
- (2015) S S Kenderian et al. LEUKEMIA
- Treatment of CD33-directed Chimeric Antigen Receptor-modified T Cells in One Patient With Relapsed and Refractory Acute Myeloid Leukemia
- (2015) Quan-shun Wang et al. MOLECULAR THERAPY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
- (2015) Anna Martner et al. Oncotarget
- Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
- (2015) Jieming Zeng et al. Scientific Reports
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
- (2015) Valentina Folgiero et al. Oncotarget
- CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
- (2014) M. K. Gleason et al. BLOOD
- Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis
- (2014) Nicolas Dulphy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia
- (2014) A Baragaño Raneros et al. GENES AND IMMUNITY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis
- (2014) M Stern et al. LEUKEMIA
- Minor histocompatibility antigens: past, present, and future
- (2014) Eric Spierings TISSUE ANTIGENS
- Treatment of Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
- (2014) Amir T. Fathi et al. Current Hematologic Malignancy Reports
- Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
- (2014) Aroa Baragaño Raneros et al. OncoImmunology
- HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation
- (2013) Amer M. Zeidan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
- (2013) F. Mussai et al. BLOOD
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
- (2013) M. S. Kung Sutherland et al. BLOOD
- Targeting Natural Killer Cells to Acute Myeloid Leukemia In Vitro with a CD16 x 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
- (2013) A. Wiernik et al. CLINICAL CANCER RESEARCH
- Dendritic-Cell-Based Therapeutic Cancer Vaccines
- (2013) Karolina Palucka et al. IMMUNITY
- Transcriptional Regulation of IL-15 Expression during Hematopoiesis
- (2013) S. L. Colpitts et al. JOURNAL OF IMMUNOLOGY
- Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
- (2013) Sung Won Choi et al. LANCET ONCOLOGY
- Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation
- (2013) T Schroeder et al. LEUKEMIA
- Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
- (2013) T Schroeder et al. LEUKEMIA
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Fusions between dendritic cells and whole tumor cells as anticancer vaccines
- (2013) Shigeo Koido et al. OncoImmunology
- Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
- (2012) Pramila Krishnamurthy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT
- (2012) C. Toffalori et al. BLOOD
- Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease
- (2012) H. Tsukamoto et al. BLOOD
- IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
- (2012) N. Cieri et al. BLOOD
- Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning
- (2012) S Maury et al. BONE MARROW TRANSPLANTATION
- Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity
- (2012) S. Hong et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia
- (2012) Luca Vago et al. SEMINARS IN ONCOLOGY
- Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Friedrich Stölzel et al. TRANSPLANTATION
- Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
- (2011) Miguel Waterhouse et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients
- (2011) Beatriz Sanchez-Correa et al. IMMUNOLOGY AND CELL BIOLOGY
- Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
- (2011) U Platzbecker et al. LEUKEMIA
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
- (2010) J. Choi et al. BLOOD
- Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
- (2010) O. Goodyear et al. BLOOD
- Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse
- (2010) S Thiant et al. BONE MARROW TRANSPLANTATION
- Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome
- (2010) M Carlsten et al. LEUKEMIA
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
- (2010) Pawel Kalinski et al. SEMINARS IN IMMUNOLOGY
- Relapse after Allogeneic Hematopoietic Cell Therapy
- (2009) Marcel R.M. van den Brink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
- (2009) L. I. Sanchez-Abarca et al. BLOOD
- 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis
- (2009) A Czibere et al. BONE MARROW TRANSPLANTATION
- Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
- (2009) Liqing Jin et al. Cell Stem Cell
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
- (2009) Albert Lin et al. IMMUNOLOGY LETTERS
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
- (2009) Fabio Ciceri et al. LANCET ONCOLOGY
- Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
- (2009) Luca Vago et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graft-versus-leukemia effects of transplantation and donor lymphocytes
- (2008) H.-J. Kolb BLOOD
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- (2008) A. Bashey et al. BLOOD
- Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy
- (2008) L. Hambach et al. BLOOD
- The importance of the indirect pathway of allorecognition in clinical transplantation
- (2008) M Refik Gökmen et al. CURRENT OPINION IN IMMUNOLOGY
- Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation
- (2008) Guanghua Chen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Donor Regulatory T Cells Identified by FoxP3 Expression but Also by the Membranous CD4+CD127low/neg Phenotype Influence Graft-versus-tumor Effect After Donor Lymphocyte Infusion
- (2008) Yosr Hicheri et al. JOURNAL OF IMMUNOTHERAPY
- T cell allorecognition and MHC restriction—A case of Jekyll and Hyde?
- (2007) Julia K. Archbold et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now